These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 16963113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment.
    Kim WY, Vezina P, Kim JH.
    Behav Brain Res; 2008 Aug 05; 191(1):62-6. PubMed ID: 18433894
    [Abstract] [Full Text] [Related]

  • 3. Microinjection of CART peptide 55-102 into the nucleus accumbens core inhibits the expression of conditioned hyperactivity in a cocaine-associated environment.
    Yoon HS, Kim WY, Kim JH.
    Behav Brain Res; 2010 Feb 11; 207(1):169-73. PubMed ID: 19818812
    [Abstract] [Full Text] [Related]

  • 4. Locomotor activity and motor disturbances induced by the competitive NMDA receptor antagonist CGP 37849.
    Kolasiewicz W, Maj J.
    Pol J Pharmacol; 1996 Feb 11; 48(5):467-79. PubMed ID: 9112688
    [Abstract] [Full Text] [Related]

  • 5. Effects of the competitive N-methyl-D-aspartate receptor antagonist, LY235959 [(-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid], on responding for cocaine under both fixed and progressive ratio schedules of reinforcement.
    Allen RM, Carelli RM, Dykstra LA, Suchey TL, Everett CV.
    J Pharmacol Exp Ther; 2005 Oct 11; 315(1):449-57. PubMed ID: 16024734
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of intrathecal glutamatergic drugs on locomotion. II. NMDA and AP-5 in intact and late spinal cats.
    Giroux N, Chau C, Barbeau H, Reader TA, Rossignol S.
    J Neurophysiol; 2003 Aug 11; 90(2):1027-45. PubMed ID: 12904502
    [Abstract] [Full Text] [Related]

  • 8. Critical role for ventral tegmental glutamate in preference for a cocaine-conditioned environment.
    Harris GC, Aston-Jones G.
    Neuropsychopharmacology; 2003 Jan 11; 28(1):73-6. PubMed ID: 12496942
    [Abstract] [Full Text] [Related]

  • 9. Neurokinin 3 receptor activation potentiates the psychomotor and nucleus accumbens dopamine response to cocaine, but not its place conditioning effects.
    Jocham G, Lauber AC, Müller CP, Huston JP, de Souza Silva MA.
    Eur J Neurosci; 2007 Apr 11; 25(8):2457-72. PubMed ID: 17445241
    [Abstract] [Full Text] [Related]

  • 10. Effects of pre- or post-training entorhinal cortex AP5 injection on fear conditioning.
    Schenberg EE, Soares JC, Oliveira MG.
    Physiol Behav; 2005 Nov 15; 86(4):508-15. PubMed ID: 16182326
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cocaine sensitization does not alter SP effects on locomotion or excitatory synaptic transmission in the NAc of rats.
    Kombian SB, Ananthalakshmi KV, Zidichouski JA, Saleh TM.
    Neuropharmacology; 2012 Feb 15; 62(2):825-32. PubMed ID: 21930135
    [Abstract] [Full Text] [Related]

  • 13. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin or accumbens dopamine, but not caffeine.
    Pulvirenti L, Swerdlow NR, Koob GF.
    Pharmacol Biochem Behav; 1991 Dec 15; 40(4):841-5. PubMed ID: 1687766
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission.
    Pierce RC, Meil WM, Kalivas PW.
    Psychopharmacology (Berl); 1997 Sep 15; 133(2):188-95. PubMed ID: 9342786
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Medial prefrontal cortex infusions of bupivacaine or AP-5 block extinction of amphetamine conditioned place preference.
    Hsu E, Packard MG.
    Neurobiol Learn Mem; 2008 May 15; 89(4):504-12. PubMed ID: 17905604
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.